Outset Medical (OM) Stock Price

Outset Medical Price

🇺🇸NASDAQ·CLOSED
3.64USD
Market closed
Today +/-
+0.11 USD
Today %
+3.21 %

Outset Medical (OM) Stock | ISIN US6901452069 | WKN A2QB2U. The current Outset Medical stock price is 3.64 USD (2026). Revenue is 130.42 M USD. Net income is -49.68 M USD. The P/E ratio is -1.11. Market capitalization is 65.98 M USD. Outset Medical operates in the Health sector.

Outset Medical stock price

Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Outset Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Outset Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Outset Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Outset Medical Stock Price History
DateOutset Medical Price
3/27/20263.64 USD
3/25/20263.52 USD
3/24/20263.53 USD
3/23/20263.53 USD
3/22/20263.62 USD
3/19/20263.36 USD
3/18/20263.37 USD
3/17/20263.35 USD
3/16/20263.61 USD
3/15/20263.35 USD
3/12/20263.26 USD
3/11/20263.16 USD
3/10/20263.26 USD
3/9/20263.18 USD
3/8/20263.22 USD
3/5/20263.18 USD
3/4/20263.44 USD
3/3/20263.53 USD
3/2/20263.48 USD
3/1/20263.57 USD
2/26/20263.49 USD
2/25/20263.64 USD
2/24/20263.37 USD
2/23/20263.34 USD
2/22/20263.35 USD
2/19/20263.53 USD
2/18/20263.53 USD
2/17/20263.47 USD
2/16/20263.25 USD
2/12/20263.39 USD
2/11/20263.8 USD
2/10/20264.54 USD
2/9/20264.7 USD
2/8/20264.65 USD
2/5/20264.5 USD
2/4/20264.39 USD
2/3/20264.9 USD
2/2/20265.04 USD
2/1/20264.97 USD
1/29/20265.01 USD
1/28/20265.07 USD
1/27/20265.03 USD
1/26/20265.68 USD
1/25/20264.97 USD
1/22/20265.11 USD
1/21/20265.4 USD
1/20/20265.2 USD
1/19/20265.05 USD
1/15/20265.3 USD
1/14/20265.26 USD
1/13/20265.48 USD
1/12/20265.12 USD
1/11/20265.57 USD
1/8/20264.56 USD
1/7/20264.67 USD
1/6/20264.34 USD
1/5/20264.29 USD
1/4/20263.8 USD
1/1/20263.7 USD
12/30/20253.71 USD
12/29/20253.62 USD
12/28/20253.54 USD
12/25/20253.36 USD
12/23/20253.29 USD
12/22/20253.32 USD
12/21/20253.68 USD
12/18/20253.7 USD
12/17/20253.61 USD
12/16/20253.77 USD
12/15/20253.92 USD
12/14/20253.97 USD
12/11/20254.18 USD
12/10/20254.29 USD
12/9/20254.4 USD
12/8/20254.36 USD
12/7/20254.34 USD
12/4/20254.39 USD
12/3/20254.72 USD
12/2/20254.31 USD
12/1/20254.05 USD
11/30/20254.22 USD
11/27/20254.56 USD
11/25/20254.44 USD
11/24/20254.47 USD
11/23/20254.33 USD
11/20/20254.29 USD
11/19/20254.44 USD
11/18/20254.57 USD
11/17/20254.97 USD
11/16/20254.92 USD
11/13/20254.68 USD
11/12/20254.9 USD
11/11/20255.54 USD
11/10/20256.22 USD
11/9/202512.07 USD
11/6/202512.06 USD
11/5/202511.81 USD
11/4/202512.56 USD
11/3/202512.77 USD
11/2/202513.01 USD
10/30/202513.12 USD
10/29/202512.63 USD
10/28/202513.48 USD
10/27/202514.21 USD
10/26/202514.38 USD
10/23/202514.75 USD
10/22/202515.2 USD
10/21/202515.05 USD
10/20/202515.27 USD
10/19/202515.53 USD
10/16/202513.25 USD
10/15/202513.33 USD
10/14/202513.57 USD
10/13/202513.38 USD
10/12/202512.61 USD
10/9/202512.45 USD
10/8/202515.11 USD
10/7/202515.81 USD
10/6/202515.01 USD
10/5/202514.88 USD
10/2/202514.49 USD
10/1/202514.09 USD
9/30/202514.02 USD
9/29/202514.12 USD
9/28/202514.49 USD
9/25/202514.52 USD
9/24/202514.71 USD
9/23/202514.79 USD
9/22/202514.85 USD
9/21/202515.77 USD
9/18/202514.18 USD
9/17/202514.17 USD
9/16/202513.93 USD
9/15/202513.85 USD
9/14/202513.72 USD
9/11/202513.69 USD
9/10/202514.15 USD
9/9/202513.54 USD
9/8/202514.19 USD
9/7/202513.81 USD
9/4/202514.01 USD
9/3/202513.35 USD
9/2/202513.77 USD
9/1/202513.74 USD
8/28/202513.91 USD
8/27/202513.92 USD
8/26/202513.96 USD
8/25/202514.1 USD
8/24/202513.72 USD
8/21/202514.2 USD
8/20/202513.67 USD
8/19/202513.34 USD
8/18/202513.35 USD
8/17/202513.67 USD
8/14/202513.29 USD
8/13/202512.89 USD
8/12/202513.21 USD
8/11/202512.67 USD
8/10/202512.43 USD
8/7/202512.8 USD
8/6/202514.18 USD
8/5/202513.17 USD
8/4/202514.1 USD
8/3/202514.16 USD
7/31/202515.04 USD
7/30/202516.06 USD
7/29/202516.9 USD
7/28/202517.54 USD
7/27/202518.04 USD
7/24/202518.53 USD
7/23/202517.61 USD
7/22/202519.44 USD
7/21/202518.95 USD
7/20/202517.51 USD
7/17/202517.42 USD
7/16/202517.6 USD
7/15/202518.1 USD
7/14/202518.08 USD
7/13/202518.81 USD
7/10/202519.39 USD
7/9/202520.61 USD
7/8/202520.52 USD
7/7/202520.9 USD
7/6/202520.45 USD
7/2/202520.9 USD
7/1/202520.58 USD
6/30/202520.73 USD
6/29/202519.21 USD
6/26/202519.07 USD
6/25/202520.13 USD
6/24/202519.56 USD
6/23/202519.97 USD
6/22/202517.37 USD
6/19/202518.98 USD
6/17/202519.57 USD
6/16/202518.94 USD
6/15/202520.46 USD
6/12/202519.96 USD
6/11/202520.28 USD
6/10/202520.43 USD
6/9/202520.65 USD
6/8/202521.24 USD
6/5/202520.93 USD
6/4/202520.06 USD
6/3/202519.32 USD
6/2/202519.41 USD
6/1/202517.81 USD
5/29/202517.57 USD
5/28/202517.61 USD
5/27/202519.5 USD
5/26/202518.79 USD
5/22/202517.95 USD
5/21/202518.47 USD
5/20/202518.6 USD
5/19/202519.51 USD
5/18/202519.58 USD
5/15/202519.5 USD
5/14/202519.55 USD
5/13/202518.5 USD
5/12/202517.24 USD
5/11/202516.29 USD
5/8/202515.3 USD
5/7/202515.88 USD
5/6/202511.74 USD
5/5/202511.54 USD
5/4/202511.78 USD
5/1/202512.25 USD
4/30/202511.17 USD
4/29/202510.64 USD
4/28/202511.44 USD
4/27/202511.61 USD
4/24/202511.58 USD
4/23/202510.86 USD
4/22/202511.25 USD
4/21/202510.68 USD
4/20/20259.98 USD
4/16/202511.01 USD
4/15/202510.91 USD
4/14/202511.38 USD
4/13/202511.06 USD
4/10/202510.16 USD
4/9/20259.6 USD
4/8/20259.94 USD
4/7/20259.49 USD
4/6/20259.58 USD
4/3/202510.89 USD
4/2/202511.07 USD
4/1/202512.15 USD
Access this data via the Eulerpool API

Outset Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
2 M USD
-46.6 M USD
-73.1 M USD
Jan 1, 2019
15.1 M USD
-70.3 M USD
-85.5 M USD
Jan 1, 2020
49.9 M USD
-117.4 M USD
-79.3 M USD
Jan 1, 2021
102.6 M USD
-130.5 M USD
-131.9 M USD
Jan 1, 2022
115.4 M USD
-161 M USD
-163 M USD
Jan 1, 2023
130.38 M USD
-169.77 M USD
-172.8 M USD
Jan 1, 2024
113.69 M USD
-108.4 M USD
-127.98 M USD
Jan 1, 2025
119.48 M USD
-66.09 M USD
-81.65 M USD
Invalid Date
130.42 M USD
-43.59 M USD
-49.68 M USD
Invalid Date
145.02 M USD
-37.87 M USD
-44.87 M USD
Invalid Date
165.21 M USD
-16.38 M USD
-25.61 M USD
Invalid Date
187.15 M USD
-6.28 M USD
-15.7 M USD
Invalid Date
208.68 M USD
8.55 M USD
1.12 M USD
Access this data via the Eulerpool API

Outset Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Apr 1, 2026, 5:36 PM
 
REVENUE (M USD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M USD)
NET INCOME (k USD)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
2023202420252026e2027e2028e2029e2030e
130113119130145165187208
13.04-13.085.319.2411.5413.7913.3311.23
22.3133.6338.6635.3831.7227.8824.622.12
2938464646464646
-172,000-127,000-81,000-49,000-44,000-25,000-15,0001,000
5.52-26.16-36.22-39.51-10.2-43.18-40-106.67
49.593.4615.2115.2115.2115.2115.2115.21
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Outset Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Outset Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Outset Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Outset Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Outset Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Access this data via the Eulerpool API

Outset Medical stock margins

The Outset Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Outset Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Outset Medical.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
-305 %
-2,330 %
-3,655 %
Jan 1, 2019
-117.88 %
-465.56 %
-566.23 %
Jan 1, 2020
-26.05 %
-235.27 %
-158.92 %
Jan 1, 2021
7.41 %
-127.19 %
-128.56 %
Jan 1, 2022
15.42 %
-139.51 %
-141.25 %
Jan 1, 2023
22.24 %
-130.22 %
-132.54 %
Jan 1, 2024
33.92 %
-95.35 %
-112.57 %
Jan 1, 2025
39.13 %
-55.31 %
-68.34 %
Invalid Date
39.13 %
-33.43 %
-38.09 %
Invalid Date
39.13 %
-26.11 %
-30.94 %
Invalid Date
39.13 %
-9.91 %
-15.5 %
Access this data via the Eulerpool API

Outset Medical Stock Revenue, EBIT, Earnings per Share

The Outset Medical earnings per share therefore indicates how much revenue Outset Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.04 USD
-1.03 USD
-1.62 USD
Jan 1, 2019
0.33 USD
-1.56 USD
-1.89 USD
Jan 1, 2020
1.17 USD
-2.75 USD
-1.86 USD
Jan 1, 2021
2.25 USD
-2.86 USD
-2.89 USD
Jan 1, 2022
2.39 USD
-3.34 USD
-3.38 USD
Jan 1, 2023
2.63 USD
-3.42 USD
-3.48 USD
Jan 1, 2024
32.83 USD
-31.3 USD
-36.95 USD
Jan 1, 2025
7.85 USD
-4.34 USD
-5.37 USD
Invalid Date
7.19 USD
-2.87 USD
-2.74 USD
Invalid Date
7.99 USD
-2.49 USD
-2.47 USD
Invalid Date
9.1 USD
-1.08 USD
-1.41 USD
Access this data via the Eulerpool API

Outset Medical business model & stock analysis

Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 313 full-time employees. The company went IPO on 2020-09-15. The firm offers Tablo, a dialysis machine. Tablo offers acute and chronic dialysis. Tablo produces dialysate that’s customized to the patient’s prescription. Its touchscreen guidance and animated instructions enables to train new users. Tablo has integrated water purification and produces dialysis on demand. The other features of Tablo include integrated blood pressure cuff and automated saline bolus and tracking. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to a single platform from the hospital to the home. The three subtypes of hemodialysis that are used in the hospital are Intermittent Hemodialysis (IHD), Slow Low Efficiency Dialysis (SLED) and CRRT. IHD is used at the bedside or an inpatient dialysis unit outside of the ICU, while SLED and CRRT are used in the ICU.
Access this data via the Eulerpool API

Outset Medical Segments

Outset Medical Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • Max

Product Revenue
Product
Service and Other Revenue
Details
Date
Product Revenue
Product
Service and Other Revenue
Jan 1, 2020
39.61 M USD
0 USD
10.32 M USD
Jan 1, 2021
0 USD
84.31 M USD
18.29 M USD
Jan 1, 2022
93.39 M USD
0 USD
21.99 M USD
Jan 1, 2024
0 USD
80.98 M USD
32.71 M USD
Jan 1, 2025
0 USD
84.81 M USD
34.67 M USD

Outset Medical Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • Max

Consumables Product
Consoles Product
Details
Date
Consumables Product
Consoles Product
Jan 1, 2020
6.74 M USD
3.1 M USD
Jan 1, 2021
19.18 M USD
65.13 M USD
Jan 1, 2022
28.8 M USD
64.59 M USD
Jan 1, 2024
51.15 M USD
29.83 M USD
Jan 1, 2025
54.08 M USD
30.73 M USD
Access this data via the Eulerpool API

Outset Medical Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Access this data via the Eulerpool API

Outset Medical historical P/E ratio, EBIT multiple, and P/S ratio

Access this data via the Eulerpool API
Access this data via the Eulerpool API

Outset Medical shares outstanding

The number of shares was Outset Medical in 2025 — This indicates how many shares 15.211 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
45.2 M base_Shares
Jan 1, 2019
45.2 M base_Shares
Jan 1, 2020
42.7 M base_Shares
Jan 1, 2021
45.6 M base_Shares
Jan 1, 2022
48.2 M base_Shares
Jan 1, 2023
49.59 M base_Shares
Jan 1, 2024
3.46 M base_Shares
Jan 1, 2025
15.21 M base_Shares
Invalid Date
15.21 M base_Shares
Invalid Date
15.21 M base_Shares
Invalid Date
15.21 M base_Shares
Access this data via the Eulerpool API
Price targets and forecasts for Outset Medical are not yet available.
Access this data via the Eulerpool API

Outset Medical Earnings Estimates

Outset Medical Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
2/11/2026-0.66USD27.45 MUSD2025 Q4
1/5/2026-0.66USD26.93 MUSD2025 Q4
5/1/2024-0.54USD33.57 MUSD2024 Q1
2/12/2024-0.63USD31.03 MUSD2023 Q4
7/31/2023-0.68USD35.35 MUSD2023 Q2
5/2/2023-0.67USD32.4 MUSD2023 Q1
2/14/2023-0.82USD29.51 MUSD2022 Q4
11/8/2022-0.83USD25.6 MUSD2022 Q3
8/1/2022-0.72USD27.9 MUSD2022 Q2
5/4/2022-0.74USD30.56 MUSD2022 Q1

EESG©

Eulerpool ESG Scorecard© for the Outset Medical stock

32/100
11
Environment
48
Social
36
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees33.8
Percentage of women in management
Percentage of Asian employees21
Share of Asian management30.4
Percentage of Hispanic/Latino employees9
Hispano/Latino Management share1.8
Percentage of Black employees7.3
Black Management Share1.8
Percentage of white employees60.2
White Management Share62.5
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Access this data via the Eulerpool API

Outset Medical shareholder structure

% Name
14.1597%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
9.17205%
PFM Health Sciences, LP
PFM Health Sciences, LP
9.13017%
Durable Capital Partners LP
Durable Capital Partners LP
8.9451%
T. Rowe Price Investment Management, Inc.
T. Rowe Price Investment Management, Inc.
8.06932%
Alyeska Investment Group, L.P.
Alyeska Investment Group, L.P.
7.3046%
Woodline Partners LP
Woodline Partners LP
5.46242%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
4.9797%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
4.59137%
Perceptive Advisors LLC
Perceptive Advisors LLC
3.48024%
MFS Investment Management
MFS Investment Management
...
Access this data via the Eulerpool API

Outset Medical Executives and Management Board

LT

Ms. Leslie Trigg

(54)

Chairman of the Board, President, Chief Executive Officer · since 2014

Compensation4 M USD
JB

Mr. John Brottem

(51)

General Counsel, Secretary

Compensation1.51 M USD
BL

Mr. Brent Lang

(57)

Independent Director

Compensation402,923 USD
DG

Mr. D. Keith Grossman

(65)

Lead Independent Director

Compensation200,000 USD
PH

Mr. Patrick Hackett

(63)

Independent Director

Compensation160,571 USD
Access this data via the Eulerpool API

Outset Medical Supply Chain

Access this data via the Eulerpool API

Frequently asked questions about Outset Medical

Access this data via the Eulerpool API

All fundamentals and in-depth analysis of Outset Medical

Our stock analysis for Outset Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Outset Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.